Bristol-Myers Squibb Revenue 2006-2018 | BMY
Bristol-Myers Squibb annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bristol-Myers Squibb revenue for the quarter ending September 30, 2018 was $5.691B, a 8.32% increase year-over-year.
- Bristol-Myers Squibb revenue for the twelve months ending September 30, 2018 was $22.037B, a 7.13% increase year-over-year.
- Bristol-Myers Squibb annual revenue for 2017 was $20.776B, a 6.94% increase from 2016.
- Bristol-Myers Squibb annual revenue for 2016 was $19.427B, a 17.31% increase from 2015.
- Bristol-Myers Squibb annual revenue for 2015 was $16.56B, a 4.29% increase from 2014.
Bristol-Myers Squibb Annual Revenue
(Millions of US $) |
| 2017 |
$20,776 |
| 2016 |
$19,427 |
| 2015 |
$16,560 |
| 2014 |
$15,879 |
| 2013 |
$16,385 |
| 2012 |
$17,621 |
| 2011 |
$21,244 |
| 2010 |
$19,484 |
| 2009 |
$18,808 |
| 2008 |
$17,715 |
| 2007 |
$15,617 |
| 2006 |
$16,208 |
| 2005 |
$18,605 |
Bristol-Myers Squibb Quarterly Revenue
(Millions of US $) |
| Q3 2018 |
$5,691 |
| Q2 2018 |
$5,704 |
| Q1 2018 |
$5,193 |
| Q4 2017 |
$5,449 |
| Q3 2017 |
$5,254 |
| Q2 2017 |
$5,144 |
| Q1 2017 |
$4,929 |
| Q4 2016 |
$5,243 |
| Q3 2016 |
$4,922 |
| Q2 2016 |
$4,871 |
| Q1 2016 |
$4,391 |
| Q4 2015 |
$4,287 |
| Q3 2015 |
$4,069 |
| Q2 2015 |
$4,163 |
| Q1 2015 |
$4,041 |
| Q4 2014 |
$4,258 |
| Q3 2014 |
$3,921 |
| Q2 2014 |
$3,889 |
| Q1 2014 |
$3,811 |
| Q4 2013 |
$4,441 |
| Q3 2013 |
$4,065 |
| Q2 2013 |
$4,048 |
| Q1 2013 |
$3,831 |
| Q4 2012 |
$4,191 |
| Q3 2012 |
$3,736 |
| Q2 2012 |
$4,443 |
| Q1 2012 |
$5,251 |
| Q4 2011 |
$5,454 |
| Q3 2011 |
$5,345 |
| Q2 2011 |
$5,434 |
| Q1 2011 |
$5,011 |
| Q4 2010 |
$5,111 |
| Q3 2010 |
$4,798 |
| Q2 2010 |
$4,768 |
| Q1 2010 |
$4,807 |
| Q4 2009 |
$5,033 |
| Q3 2009 |
$4,788 |
| Q2 2009 |
$4,665 |
| Q1 2009 |
$4,322 |
| Q4 2008 |
$2,367 |
| Q3 2008 |
$5,254 |
| Q2 2008 |
$5,203 |
| Q1 2008 |
$4,891 |
| Q4 2007 |
$2,228 |
| Q3 2007 |
$4,601 |
| Q2 2007 |
$4,471 |
| Q1 2007 |
$4,317 |
| Q4 2006 |
$2,507 |
| Q3 2006 |
$4,154 |
| Q2 2006 |
$4,871 |
| Q1 2006 |
$4,676 |
| Q4 2005 |
$4,417 |
| Q3 2005 |
$4,767 |
| Q2 2005 |
$4,889 |
| Q1 2005 |
$4,532 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$81.643B |
$20.776B |
|
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D; organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
|